financetom
Business
financetom
/
Business
/
UBS Q1 Earnings, Revenue Advance -- Shares Higher Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
UBS Q1 Earnings, Revenue Advance -- Shares Higher Pre-Bell
May 7, 2024 4:08 AM

06:37 AM EDT, 05/07/2024 (MT Newswires) -- UBS (UBS) reported Q1 earnings Tuesday of $0.52 per diluted share, up from $0.32 a year earlier.

Revenue for the quarter ended March 31 was $12.74 billion, up from $8.74 billion a year earlier.

Comparable analyst estimates were not available.

Shares of the global investment bank were up more than 9% in recent Tuesday premarket activity.

Price: 30.13, Change: +2.53, Percent Change: +9.17

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US M&A momentum accelerates: EY-Parthenon forecasts 2026 deal activity to surpass 2025
US M&A momentum accelerates: EY-Parthenon forecasts 2026 deal activity to surpass 2025
Oct 28, 2025
Dealmakers shift from recovery to resilient growth, driven by strategic AI-driven transformation. Resilient volume growth: Total US deal volume (for deals more than $100 million) is expected to grow 3% in 2026, following an anticipated 9% rise in 2025. Surge in deal value will continue: Year-to-date deal value is up 36% over 2024, driven by a strong uptick in larger deals that...
Incyte boosts annual sales forecast of blood cancer drug after strong quarter
Incyte boosts annual sales forecast of blood cancer drug after strong quarter
Oct 28, 2025
Oct 28 (Reuters) - Drugmaker Incyte Corp on Tuesday raised its annual sales forecast for its blood cancer treatment Jakafi after robust demand for the drug helped the company surpass Wall Street estimates for third-quarter revenue and profit. However, shares fell 2.4% in premarket trading after the company said it halted two new drug programs and stopped developing povorcitinib for...
ORACLE says there is real value in AI as demand far outpaces supply
ORACLE says there is real value in AI as demand far outpaces supply
Oct 28, 2025
RIYADH, Oct 28 (Reuters) - Oracle CEO Mike Sicilia said on Tuesday that he is not concerned about an AI bubble, adding that there is real value in artificial intelligence as demand far outpaces supply. He was speaking at a panel the annual Future Investment Initiative (FII) summit in Riyadh. ...
Adobe reworks its apps for AI assistants, pursues ChatGPT integration
Adobe reworks its apps for AI assistants, pursues ChatGPT integration
Oct 28, 2025
SAN FRANCISCO, Oct 28 (Reuters) - Adobe said on Tuesday its video and image editing tools can be controlled by chatting with them, adding that it is working with ChatGPT creator OpenAI to let users directly control one of its apps with the popular chatbot service. Adobe is the creator of Photoshop and Premiere, widely used tools in the photography...
Copyright 2023-2026 - www.financetom.com All Rights Reserved